Power Finance Corp Shares Drop; Price Target at ₹520by Mark Eisenberg 25.06.2024Power Finance Corp share price drops to ₹484.05, signaling short-term bearish trends despite strong buy ratings and a target of ...
Salesforce Exec Tallapragada Sells $228K in Sharesby Mark Eisenberg 25.06.2024Salesforce exec Srinivas Tallapragada sells $228K in shares to cover taxes; Salesforce sees 11% revenue rise, strong market position, and ...
ARK Invest Reshuffles Biotech, Sells Coinbase & Ginkgoby Lilu Anderson 25.06.2024Cathie Wood's ARK shifts focus, selling Ginkgo and Coinbase, while investing in 10X Genomics and Roku in a biotech-centered portfolio ...
Enerpac Slides 9% on Q3 Revenue Miss – Strong Balance Sheetby Mark Eisenberg 25.06.2024Enerpac shares dropped 9% after a Q3 revenue miss despite EPS meeting expectations and improvements in gross margin and EBITDA.
Tom Lee Explains Bold $150K Bitcoin Price Predictionby John Darbie 25.06.2024Tom Lee explains his Bitcoin price predictions, highlighting cooperative value, active wallets, and unique security, with a $150,000 target.
Brazil Stocks Climb: Bovespa Index Gains 1.07%by Mark Eisenberg 25.06.2024"Brazil Stocks Rally with Bovespa Up 1.07%; Top Gainers Include Magazine Luiza, MRV Engenharia. Market Stability Evident as Volatility Drops."
HireQuest CEO Buys $12.9K in Stock Amid Market Strugglesby Mark Eisenberg 25.06.2024HireQuest CEO buys $12.9K in shares, signaling strong confidence in company’s future amidst tough market and positive Q1 financials.
Kaltura Exec Sells $2,278 in Stock Amid Planned Strategyby Mark Eisenberg 25.06.2024Kaltura's Chief Customer Officer Natan Israeli sells company stock under a 10b5-1 plan, retaining a strong shareholding, reflecting confidence in ...
Nvidia’s CFO Jankowski Leaves for Startup, Cites Tough Decisionby Mark Eisenberg 25.06.2024Nvidia's VP of Finance, Simona Jankowski, departs for a startup role, marking a notable shift amid Nvidia's monumental growth and ...
CTT Pharma CEO Buys $70 in Stock, Owns 5M+ Sharesby Mark Eisenberg 25.06.2024CTT Pharmaceutical CEO buys $70 in stock, signaling confidence. Despite recent gains, profitability concerns remain. Investors should monitor closely.